Metal Allergy and Implants: Testing Challenges, Guidelines, and Clinical Controversies

Conclusions

• Metal allergy remains a real but uncommon and difficult-to-define problem in implanted devices, especially because evidence linking allergy to implant failure is inconsistent.
• Patch testing is the main available diagnostic tool, but it only identifies current cutaneous allergy and does not reliably reproduce the deep joint environment or prove causation.
• Pre-implant patch testing is most useful when a patient already has a convincing history of metal allergy, rather than as universal screening.
• Post-implant positive patch tests should be interpreted cautiously because sensitization from the implant may occur and a positive result does not necessarily explain pain or failure.
• When implant-related hypersensitivity is suspected, infection, mechanical failure, loosening, malalignment, and other causes of symptoms must be excluded first.
• Patients with metal allergy can still do well with standard implants, and patients without known allergy can still develop implant problems, so allergy alone is not a dependable predictor of outcome.
• If testing is done, the workup should include not only metals such as nickel, cobalt, and chromium, but also cements, acrylates, antibiotics, and other potential allergens.
• When a patient has a clear pre-existing metal allergy and testing is positive, choosing an allergen-avoiding implant may be reasonable and sometimes helps, but the supporting studies are small and limited.
• Revision surgery should be considered a last resort because the benefit of removing an implant for suspected allergy is uncertain and the procedure carries substantial risk.
• Overall, the field needs better evidence and more robust studies before firm standards for screening and management of metal hypersensitivity in implants can be established.